Suppr超能文献

肠内营养与肠外营养对ICU患者肝血流及稳态丙泊酚药代动力学的影响。

Effect of enteral versus parenteral feeding on hepatic blood flow and steady state propofol pharmacokinetics in ICU patients.

作者信息

Van Brandt N, Hantson P, Horsmans Y, Mahieu P, Verbeeck R K

机构信息

Laboratory of Pharmacokinetics, School of Pharmacy, UCL/FATC 7355, Brussels, Belgium.

出版信息

Intensive Care Med. 1998 Aug;24(8):795-800. doi: 10.1007/s001340050668.

Abstract

OBJECTIVE

The main objective of this study was to evaluate the effect of switching from parenteral to enteral feeding on liver blood flow and propofol steady-state blood concentrations in patients in the intensive care unit (ICU).

DESIGN AND PATIENTS

Steady-state blood concentrations of propofol were measured in eight ICU patients before (on days D -3, D -2, and D -1) and after (on days D + 1, D + 2, and D + 3) switching from parenteral to enteral feeding (on day DO). All patients received a continuous intravenous infusion of propofol (4.5 mg x kg(-1) x h(-1)) from several days before the start of the study, continuing throughout the experimental period. Hepatic blood flow was estimated by measuring steady-state D-sorbitol hepatic clearance.

RESULTS

Hepatic blood flow was high and was not affected by switching from parenteral to enteral feeding: 33 +/- 8 ml x min(-1) x kg(-1) (mean +/- SD) and 33 +/- 10 ml min(-1) x kg(-1) on D -3 and D -1, respectively, as compared to 37 +/- 11 ml x min(-1) kg(-1) and 34 +/- 8 ml x min(-1) x kg(-1) on days D + 1 and D + 3, respectively. Systemic clearance of propofol was much higher than liver blood flow with average values on the six observation days ranging from 74.0 to 81.2 ml x min(-1) x kg(-1) and was not affected by switching from parenteral to enteral feeding.

CONCLUSIONS

Liver blood flow and systemic clearance of propofol were not affected by switching from parenteral to enteral feeding in the eight ICU patients studied. Extrahepatic clearance accounted for at least two thirds of the overall systemic clearance of propofol.

摘要

目的

本研究的主要目的是评估重症监护病房(ICU)患者从肠外营养转换为肠内营养对肝脏血流和丙泊酚稳态血药浓度的影响。

设计与患者

在8名ICU患者从肠外营养转换为肠内营养前(第D - 3天、D - 2天和D - 1天)和转换后(第D + 1天、D + 2天和D + 3天)(在第D0天转换)测量丙泊酚的稳态血药浓度。所有患者在研究开始前数天接受丙泊酚持续静脉输注(4.5 mg·kg⁻¹·h⁻¹),并在整个实验期间持续输注。通过测量稳态D - 山梨醇肝脏清除率估算肝脏血流。

结果

肝脏血流较高,且不受从肠外营养转换为肠内营养的影响:第D - 3天和D - 1天分别为33 ± 8 ml·min⁻¹·kg⁻¹(均值±标准差)和33 ± 10 ml·min⁻¹·kg⁻¹,相比之下,第D + 1天和D + 3天分别为37 ± 11 ml·min⁻¹·kg⁻¹和34 ± 8 ml·min⁻¹·kg⁻¹。丙泊酚的全身清除率远高于肝脏血流,六个观察日的平均值在74.0至81.2 ml·min⁻¹·kg⁻¹之间,且不受从肠外营养转换为肠内营养的影响。

结论

在本研究的8名ICU患者中,从肠外营养转换为肠内营养未影响肝脏血流和丙泊酚的全身清除率。肝外清除率至少占丙泊酚总体全身清除率的三分之二。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验